NRX Pharmaceuticals Inc. Revenue 2023–2025
NRX Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- NRX Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 1.1 M.
- NRX Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 1.3 M.
- NRX Pharmaceuticals Inc. annual revenue for 2025 was 1.2 M.
- NRX Pharmaceuticals Inc. annual revenue for 2024 was 0.
- NRX Pharmaceuticals Inc. annual revenue for 2023 was 0.
NRX Pharmaceuticals Inc. (NRXP) — Frequently Asked Questions
NRX Pharmaceuticals Inc. (NRXP) is a publicly traded US company. It has a market capitalization of $119M. In fiscal 2025 it reported revenue of $1M and net income of -$29M. Explore NRXP's stock price, financial statements, earnings history, margins and key ratios below.
What is NRX Pharmaceuticals Inc.'s market cap?
NRX Pharmaceuticals Inc. (NRXP) has a market capitalization of $119M.
What is the NRXP stock price?
NRXP trades at $3.76 (-2.84% on the day).
How much revenue does NRX Pharmaceuticals Inc. make?
NRX Pharmaceuticals Inc. reported revenue of $1M in fiscal 2025.
Is NRXP profitable?
In fiscal 2025, NRX Pharmaceuticals Inc. reported net income of -$29M.